Comment on

• A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.

  Freifeld A, Marchigiani D, Walsh T, Chanock S, Lewis L, Hiemenz J, Hiemenz S, Hicks JE, Gill V, Steinberg SM, Pizzo PA. Freifeld A, et al. N Engl J Med. 1999 Jul 29;341(5):305-11. doi: 10.1056/NEJM199907293410501. N Engl J Med. 1999. PMID: 10423464 Clinical Trial.
• Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer.

  Kern WV, Cometta A, De Bock R, Langenaeken J, Paesmans M, Gaya H. Kern WV, et al. N Engl J Med. 1999 Jul 29;341(5):312-8. doi: 10.1056/NEJM199907293410502. N Engl J Med. 1999. PMID: 10423465 Clinical Trial.
• Fever and neutropenia--how to use a new treatment strategy.

  Finberg RW, Talcott JA. Finberg RW, et al. N Engl J Med. 1999 Jul 29;341(5):362-3. doi: 10.1056/NEJM199907293410509. N Engl J Med. 1999. PMID: 10423472 No abstract available.